Randall Barnes to Luteinizing Hormone
This is a "connection" page, showing publications Randall Barnes has written about Luteinizing Hormone.
Connection Strength
0.457
-
The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod. 2002 Jan; 17(1):88-91.
Score: 0.205
-
The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies. J Endocrinol Invest. 1998 Oct; 21(9):567-79.
Score: 0.041
-
Pathophysiology of ovarian steroid secretion in polycystic ovary syndrome. Semin Reprod Endocrinol. 1997 May; 15(2):159-68.
Score: 0.037
-
Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study. J Clin Endocrinol Metab. 1996 Sep; 81(9):3408-11.
Score: 0.035
-
Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994 Nov; 79(5):1328-33.
Score: 0.031
-
Quantitative and qualitative tests for urinary luteinizing hormone. Comparison in spontaneous and clomiphene-citrate-treated cycles. J Reprod Med. 1990 Nov; 35(11):1051-4.
Score: 0.024
-
Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
Score: 0.021
-
The polycystic ovary syndrome: pathogenesis and treatment. Ann Intern Med. 1989 Mar 01; 110(5):386-99.
Score: 0.021
-
Identification of seminiferous tubule aberrations and a low incidence of testicular microliths associated with the development of azoospermia. Fertil Steril. 1999 Sep; 72(3):467-71.
Score: 0.011
-
Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor--a clinical research center study. J Clin Endocrinol Metab. 1996 Oct; 81(10):3802-6.
Score: 0.009
-
Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
Score: 0.008
-
Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann N Y Acad Sci. 1993 May 28; 687:162-81.
Score: 0.007
-
Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
Score: 0.007